HYPERPOLARIZED HELIUM-3 MRI OF THE LUNG IN ASTHMATICS
HYPERPOLARIZED HELIUM-3 MRI OF THE LUNG IN ASTHMATICS
批准号:
6580182
负责人:
EDUARD E DE LANGE
金额:
$0.87万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-07-01 至 2004-05-31
关键词:
albuterol allergens asthma autoradiography bioimaging /biomedical imaging computed axial tomography exercise helium human subject human therapy evaluation inhalation drug administration lung imaging /visualization /scanning magnetic resonance imaging methacholine nuclear medicine patient oriented research prognosis pulmonary respiration respiratory disease /disorder therapy respiratory disorder chemotherapy sign /symptom triamcinolone
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Verbatim from the Applicant's Abstract): Asthma is an important public health concern affecting more than l4 million people in the United
States including over 4.8 million children. Epidemiological studies show a
trend toward increasing prevalence and morbidity, but the reasons for these
increases remain unclear. Asthma is a chronic disease defined by reversible
obstruction of the small airways, inflammation, and increased airway responsiveness to a variety of stimuli: a process that disrupts adequate
ventilation of the alveoli causing dyspnea and hypoxia. Existing methods of
small airways disease are either indirect or imprecise. Hyperpolarized helium-3
(H3He) gas MR lung imaging is a new technology which allows direct
visualization of the lung airspaces, the ventilation and small airway disease,
enabling assessment of disease activity at a level that was previously
impossible to evaluate. Thus, H3He MR imaging has the potential to provide
insight into the pathophysiology of asthma and to contribute to improved
clinical management. Preliminary studies with H3He MR have demonstrated
ventilation defects in asthmatics, even when they were asymptomatic and had
normal lung function tests, and the findings suggest that this new technology
is capable of detecting subclinical disease.
The goal of the proposed research is to gain a better insight into the H3He MR
imaging characteristics in asthmatics (Specific Aim # 1) and to determine how
these findings correlate with disease activity and severity (Specific Aim #2).
In order to obtain information on the imaging characteristics, we will evaluate
the H3He MR imaging findings in populations of symptomatic and asymptomatic
asthmatics, using healthy, non-asthmatics as controls. In addition, we will
determine in small subgroups of patients how these findings compare to those
obtained with two existing lung imaging modalities, nuclear medicine
ventilation scanning and computed tomography (CT). To determine the ability of
H3He lung MR in assessing disease activity, we will evaluate the imaging
changes that occur during tests that provoke (worsen) and treat (improve)
asthma. Provocation tests include inhalation of methacholine, exercise,
administration of endobronchial allergen and viral inoculation, and treatments
include inhaled of p2agonist (albuterol) and steroids (asthmacort). The results
of the studies proposed in this research will serve as a foundation for
developing future clinical and basic research applications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HYPERPOLARIZED HELIUM-3 MRI OF THE LUNG IN ASTHMATICS
-
批准号:6537948
-
项目类别:
-
资助金额:$43.74万
-
财政年份:2001
-
负责人:EDUARD E DE LANGE
-
依托单位:
HYPERPOLARIZED HELIUM-3 MRI OF THE LUNG IN ASTHMATICS
-
批准号:6260307
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2001
-
负责人:EDUARD E DE LANGE
-
依托单位:
HYPERPOLARIZED HELIUM-3 MRI OF THE LUNG IN ASTHMATICS
-
批准号:6638734
-
项目类别:
-
资助金额:$36.85万
-
财政年份:2001
-
负责人:EDUARD E DE LANGE
-
依托单位:
海外基金